Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1111624A details a novel aprotic polar solvent synthesis offering superior thermal stability and safety over conventional NMP alternatives for industrial applications.
Patent CN101857593A discloses a novel reductive amination route for 9-aminoquinine derivatives, offering high purity and scalable production for pharmaceutical applications.
Patent CN1671686A reveals a stable route for thiophene intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel Rh-free synthesis of Sitagliptin phosphate ensuring high purity and cost efficiency for pharmaceutical supply chains.
Novel patent CN104447523B enables efficient aminopyridine production from pyridine mixtures, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101270058B details a high-yield hydrogenation route for 3-(1-dimethylaminoethyl)phenol, offering superior purity and cost efficiency for Alzheimer's drug intermediates.
Patent CN102311352B details a safe, cost-effective 3-step synthesis from m-cresol, offering significant supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN104277018B enables high-purity 2 5-dimethylaminofuran production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108752217B reveals a green, low-cost route for 2,4-difluorobenzylamine, a key dolutegravir intermediate, offering significant supply chain advantages.
Patent CN108147989B reveals a one-pot synthesis of beta-amino ketones using allyl alcohols, offering high yields and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111747971A details a novel phenothiazine dioxide-based perylene diimide material offering superior stability and cost efficiency for next-generation photovoltaic manufacturing.
Advanced preparation of Maropitant intermediates via transition metal catalysis. High purity, >99% ee, and scalable routes for pharmaceutical manufacturing.
Patent CN104860926B details a novel preparation method for Vonoprazan fumarate offering high purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Novel process for Tylvalosin precursor using Tylosin Tartrate. High yield, simplified steps, reduced solvent use. Ideal for veterinary API manufacturing.
Novel reductive amination method achieves over 80% yield and 99.5% purity, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Advanced Elagolix synthesis via reductive amination offers purity and cost benefits. Reliable supply chain partner for pharmaceutical intermediate manufacturing scale-up.
Patent CN1377337A details a novel route for COX-2 inhibitor intermediates via lactam hydrolysis. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Explore the synthesis of novel phenylethanolamine compounds for asthma treatment. Discover cost-effective manufacturing routes and reliable supply chain solutions for pharmaceutical intermediates.
Discover the novel ternary catalyst method for N-ethyl-D-glucosamine production. Achieve higher purity and yield while reducing manufacturing costs and supply chain risks.
Novel CN105859703A patent route for Brexpiprazole using 7-hydroxycoumarin. Reduces impurities, lowers cost, ensures supply chain stability for pharma manufacturing.